Working together to deliver cell and gene therapies for people impacted by serious diseases Learn More Our inspiration Learn More Pipeline Explore R&D pz-cel (prademagene zamikeracel) BLA submitted for investigational autologous, COL7A1 gene-corrected epidermal sheets for RDEB. Learn More ABO-50X Exploring the potential of ABO-50X for the treatment of genetic eye disorders. Learn More Latest News Mar 18, 2024 Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections View Press Release Mar 5, 2024 Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) View Press Release Feb 1, 2024 Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) View Press Release View All Manufacturing at The Elisa Linton Center for Rare Disease Therapies Learn More